Home » Newsletters » BioWorld Science

BioWorld Science

July 10, 2012

View Archived Issues

Scientists at Actelion Pharmaceuticals patent new FPR2/ALX receptor agonists

New MPGES-1 inhibitors designed in Germany

New long-acting drug is well tolerated as once-weekly growth hormone replacement therapy

PARP-1/2 inhibitor shows promising safety profile in patients with cancer

Lupin presents novel GLP-1 receptor modulators

New agents for cancer reported by Kasina Laila Innova Pharmaceuticals

First-in-human study of EP-100 complete

Ampio Pharmaceticals discloses data from Optina trial

Novel DPP IV inhibitors prepared

OncoSec launches new phase II OMS ElectroImmunotherapy trial

DNAzyme is effective in models of skin cancer

FDA grants priority review for Xarelto applications

Proteostasis Therapeutics discloses novel prosteostasis regulators

ACT clear to proceed with dry AMD trial

Repros reaches agreement with FDA on pivotal Androxal studies

Titan Pharmaceuticals completes study of nonfluctuating dopamine receptor agonist drug

Lux Biosciences completes enrollment in phase III trial in noninfectious uveitis

TONIX reports encouraging pharmacokinetic data on TNX-102

Potential biomarker of AMD identified

Acusphere gives update on MAA for Imagify

FDA places clinical hold on IB-1001 trials

Pergamum reports topline data from phase II trial in prevention of postsurgical adhesions

Sanofi withdraws MAA for anticoagulant drug

Phase III Halaven study in new breast cancer indication does not meet primary endpoints

Xiaflex approved in Canada

Norwegian government awards grant to Bionor

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
DOJ arrests shed light on Medicare skin substitute controversy
BioWorld MedTech
Much has been made of the recent skyrocketing of Medicare spending on skin substitutes, but a new enforcement action by the U.S. Department of Justice might help...